IL17A and type 2 diabetes mellitus: There were significantly higher concentrations of IL-17 in T2D patients (median, 3.84 pg/mL; range, 0.81–7.78 pg/mL) as compared with CTLs (median, 2.06 pg/mL; range, 0.81–3.04 pg/mL; *P<0.0001) and MHO patients (median, 1.91 pg/mL; range, 0.89–5.11 pg/mL; *P<0.0001).